Angiotensin 1/2 (1-9)

血管紧张素I

血管紧张素I;ASP-ARG-VAL-TYR-ILE-HIS-PRO-PHE-HIS;ALA-ARG-VAL-TYR-ILE-HIS-PRO-PHE;血管紧张素Ⅰ三氟乙酸盐;ANGIOTENSIN I (1-9)|血管紧张素I;血管紧张素I三氟乙酸盐

Angiotensin 1/2 (1-6)

ANGIOTENSIN I/II (1-6)

Angiotensin (1-7)

A779

天冬氨酰-精氨酰-缬氨酰-酪氨酰-异亮氨酰-组氨酰-脯氨酸;血管紧张素片断 1-7 乙酸盐 水合物;血管紧张素 (1-7)>98%;A779;血管紧张素 (1-7)

a-Endorphin

α-内啡肽

Α-内啡肽,≥97% ;TYR-GLY-GLY-PHE-MET-THR-SER-GLU-LYS-SER-GLN-THR-PRO-LEU-VAL-THR-LEU-PHE-LYS-ASN-ALA-ILE-ILE-LYS-ASN-ALA-TYR-LYS-LYS-GLY-GLU;ALPHA-内啡肽;Α-内啡肽;TYR-GLY-GLY-PHE-MET-THR-SER-GLU-LYS-SER-GLN-THR-PRO-LEU-VAL-THR: YGGFMTSEKSQTPLVT

Aclacinomycin A

阿克拉霉素

阿柔比星;阿克拉霉素A;阿柔比星;安乐霉素;阿柔比星,阿克拉霉素A;阿克拉霉素;阿克拉霉素;盐酸阿柔比星;安乐霉素

Elastase Inhibitor

弹性蛋白酶抑制剂

弹性蛋白酶抑制剂

YM155

4,9-二氢-1-(2-甲氧基乙基)-2-甲基-4,9-二氧代-3-(2-吡嗪甲基)-1H-萘并[2,3-D]咪唑溴化物

4,9-二氢-1-(2-甲氧基乙基)-2-甲基-4,9-二氧代-3-(2-吡嗪甲基)-1H-萘并[2,3-D]咪唑溴化物;YM-155;YM 155;CS-35;YM155 (SEPANTRONIUM BROMIDE);YM-155;YM155,一种新型小分子存活素抑制剂

LY315920 (Varespladib)

伐瑞拉迪

伐瑞拉迪;CS-68;CS-2393;伐瑞拉迪>98%;伐瑞拉地

CHR2797 (Tosedostat)

托舍多特

ALPHA-[[(2R)-2-[(1S)-1-羟基-2-(羟基氨基)-2-氧代乙基]-4-甲基-1-氧代戊基]氨基]苯乙酸环戊酯;托舍多特

TAK-700 (Orteronel)

TAK-700 (ORTERONEL)

CS-990;6-(6,7-二氢-7-羟基-5H-吡咯并[1,2-C]咪唑-7-基)-N-甲基-2-萘羧酰胺;6-[7-羟基-6,7-二氢-5H-吡咯并[1,2-C]咪唑-7-基]-N-甲基-2-萘甲酰胺

S-Ruxolitinib (INCB018424)

环丙基[4-[3-(1H-咪唑-5-基)丙氧基]苯

(3S)-3-Cyclopentyl-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]propanenitrile (ent-Ruxolitinib);(S)-3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile;S-Ruxolitinib (INCB018424);Ruxolitinib (S enantioMer);(3S)-3-Cyclopentyl-3-[4-(7H-pyrrolo[2,3-d]pyriMidin-4-yl)-1H-pyrazol-1-yl]propanenitrile;Ruxolitinib Impurity A;Ruxolitinib Impurity 1（(S)-Ruxolitinib）;S-Ruxolitinib

RITA (NSC 652287)

RITA, >99%

NSC-652287;NSC 652287;5,5'-(2,5-呋喃二基)二-2-噻吩甲醇;5,5-呋喃二基)二-2-噻吩甲醇 RITA;5-呋喃二基)二-2-噻吩甲醇

Pifithrin-alpha

Pifithrin-α (PFTα)

CS-1772;2-(2-亚氨基-4,5,6,7-四氢苯并噻唑-3-基)-1-P-苯甲基乙酮氢溴酸盐;CS-607;PIFITHRIN HYDROBROMIDE;PIFITHRIN-Α HYDROBROMIDE;PFTΑ HYDROBROMIDE;皮斐松

N-(3-Bromophenyl)-6,7-dimethoxyquinazolin-4-amine

4-[(3-溴苯基)氨基]-6,7-二甲氧基喹啉

PD153035;AG1517;PD-153035;AG-1517;ZM 252868;TYRPHOSTIN AG 1517;SU 5271;4-[(3-溴苯基)氨基]-6,7-二甲氧基喹啉;PD153035;AG1517;PD-153035;AG-1517;N-(3-溴苯基)-6,7-二甲氧基喹唑啉-4-胺;4-[(3-溴苯基)氨基]-6,7-二甲氧基喹唑啉盐酸盐;PD153035;ZM 252868;AG 1517

PCI-34051

N-羟基-1-(4-甲氧基苄基)-1H-吲哚-6-甲酰胺

N-羟基-1-(4-甲氧基苄基)-1H-吲哚-6-甲酰胺;PCI-34051;PCI 34051

obatoclax mesylate

Obatoclax 甲磺酸盐

2-[2-[(3,5-二甲基-1H-吡咯-2-基)亚甲基]-3-甲氧基-2H-吡咯-5-基]-1H-吲哚甲磺酸盐;OBATOCLAX 甲磺酸盐;CS-394;甲磺酸盐;奥巴克拉;奥巴克拉甲磺酸盐;奥巴克拉盐酸盐

MK-8245

MK-8245

CS-1662;5-[3-[4-(2-溴-5-氟苯氧基)-1-哌啶基]-5-异恶唑基]-2H-四氮唑-2-乙酸;2-(5-(3-(4-(2-溴-5-氟苯氧基)哌啶-1-基)异恶唑-5-基)-2H-四唑-2-基)乙酸;2H-四唑乙酸,5-[3-[4-(2-溴-5-氟苯氧基)-1-哌啶基]-5-异恶唑]-;MK8245;MK-8245;MK 8245;MK 8245;MK8245

MK-2206 di hydrochloride

MK-2206 2HCl

8-[4-(1-氨基环丁基)苯基]-9-苯基-1,2,4-三...;MK-2206 2HCL;MK2206;CS-260;MK 2206 2HCL;MK2206 2HCL;MK-2206 DIHYDROCHLORIDE;MK2206 DIHYDROCHLORIDE;(8-[4-(1-氨基环丁基)苯基]-9-苯基-2H-[1,4]三唑并[3,4-F][1,6]萘啶-3-酮)二盐酸盐;MK-2206 二盐酸盐,一种变构 AKT 抑制剂;MK 2206 2HCL;MK2206 2HCL;8-[4-(1-氨基环丁基)苯基]-9-苯基-1,4-三唑并[3,6]萘啶-3(2H)-酮二盐酸盐

KW-2478

KW-2478

KW-2478;2-Ethyl-3,5-dihydroxy-N,N-bis(2-methoxyethyl)-6-[3-methoxy-4-[2-(4-morpholinyl)ethoxy]benzoyl]benzeneacetamide;2-[2-ethyl-3,5-dihydroxy-6-[3-methoxy-4-(2-morpholin-4-ylethoxy)benzoyl]phenyl]-N,N-bis(2-methoxyethyl)acetamide;2-(2-ethyl-3,5-dihydroxy-6-(3-methoxy-4-(2-morpholinoethoxy)benzoyl)phenyl)-N,N-bis(2-methoxyethyl)acetamide;2-Ethyl-3,5-dihydroxy-N,N-bis(2-methoxyethyl)-6-[3-methoxy-4-[2-(4-morpholinyl)ethoxy]benzoyl]benzeneacetamide KW2478;2-(2-Ethyl-3,5-dihydroxy-6-(3-methoxy-4-(2-morpholinoethoxy)benzoyl)phenyl)-N,N-bis(2-methoxye

JNJ 1661010

JNJ 1661010

CS-1527;TAKEDA-25;JNJ-1661010;JNJ 1661010